期刊文献+

子宫腺肌病组织中SRC-3、MMP-9表达变化及意义

下载PDF
导出
摘要 目的观察子宫腺肌病(AM)组织中受体辅活化因子-3(SRC-3)、基质金属蛋白酶-9(MMP-9)的表达变化,并探讨其意义。方法选取手术切除的AM异位病灶组织42例为AM组;选择子宫肌瘤患者手术切除的非瘤区正常子宫内膜组织10例为对照组。采用组织芯片技术及免疫组化SP法检测两组子宫内膜组织中的SRC-3和MMP-9。结果 SRC-3、MMP-9在AM组子宫内膜组织的表达显著高于对照组(P均<0.01)。对照组增殖期子宫内膜组织中SRC-3、MMP-9的表达显著高于其分泌期(P均<0.05);AM组增殖期与分泌期异位子宫内膜组织中SRC-3、MMP-9的表达水平相近(P均>0.05),且均高于相应期别的对照组(P均<0.05)。AM组异位子宫内膜组织中SRC-3与MMP-9的表达呈正相关(r=0.720,P<0.05)。结论 SRC-3与MMP-9在AM异位子宫内膜组织中的表达增高,二者可能在AM的发生发展中起促进作用。
出处 《山东医药》 CAS 2013年第2期37-39,共3页 Shandong Medical Journal
基金 四川省泸州市科学技术研究项目(200727)
  • 相关文献

参考文献11

  • 1Leo C,Chen JD. The SRC family of nuclear receptor coactivators[J].Gene,2000,(01):1-11.
  • 2Liao L,Kuang SQ,Yuan Y. Molecular structure and biological of function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1[J].Journal of Steroid Biochemistry and Molecular Biology,2002,(1-5):3-14.
  • 3张丽芳,郭新华.子宫内膜癌组织核受体共激活因子SRC-1和SRC-3表达及意义[J].齐鲁医学杂志,2010,25(2):95-97. 被引量:6
  • 4Kershah SM,Desouki MM,Koterba KL. Expression of estrogen receptor coregulators in normal and malignant human endometrium[J].Gyneceol Oneol,2004,(01):304-313.
  • 5Salamonsen LA,Woolley DE. Matrix metalloproteinases in normal menstruation[J].Human Reproduction,1996,(02):124-133.
  • 6Bischof P,Campana A. Trophoblast differentiation and invasion:Its significance for human embryo implantation[J].Early Pregnancy,1997,(02):81-95.
  • 7Bruner KL,Matrisian LM,Rodgers WH. Suppression of matrix erauproteinses inhibits establishment of ectopic Lesions by human endometriom in nude mice[J].Journal of Clinical Investigation,1997,(12):2851-2857.
  • 8Marbaix E,Kokorine I,Donne J. Regulation and restricted expression of interstitial collagenase suggest a pivotal role in the initiation of menstruation[J].Human Reproduction,1996,(Suppl 2):134-143.
  • 9Li Q,Lan L,Redmond A. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression[J].Molecular and Cellular Biology,2008,(19):5937-5950.doi:10.1128/MCB.00579-08.
  • 10Li LB,Louie MC,Chen HW. Proto-oncogene ACTR/AIB1 promotes cancer cell invasion by up-regulating specific matrix metalloproteinase expression[J].Cancer Letters,2008,(01):64-73.doi:10.1016/j.canlet.2007.11.013.

二级参考文献11

  • 1郑录清,张洪文.子宫内膜癌的病因和发病机制的科学认识[J].医学与哲学(B),2006,27(5):63-65. 被引量:6
  • 2韩肖燕,郄明蓉.AIB1基因与妇科肿瘤[J].国外医学(妇产科学分册),2007,34(3):173-176. 被引量:2
  • 3FREUND K W, DOLAN N C, NELSON H D. Update in women's health[J]. AnnInt Med, 2003,138(2):119-127.
  • 4RALF T H, BASSEM R H, SUNG E K, et al. Overpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma[J].Clinical Cancer Reserch, 2004,10 : 6134-6142.
  • 5SINICROPE F A, RUAN S B, CLEARY K R, et al. bcl22 and p53 oncor protein expression during colorectal tumorigenesis[J].Cancer Res, 1995,55 : 237-241.
  • 6XU J M, LIAO L, NING G. The steroid receptor coactivator SRC-3 is required for normal groth, puberty, female reproductive function, and mammary gland development[J]. PANS, 2000,97(12) :63769-63773.
  • 7XU J M, BERT W. Molecular mechanisms and cellular biology of the steroid recepeor coactivator (SRC) family in steroid receptor function[J].Endocr Metab Disord, 2002, 3: 185- 189.
  • 8MYERS E, FLEMING F J, GROTTY T B, et al. Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine resistant breast cancer[J].Br J Cancer, 2004, 91(9):1687-1692.
  • 9KERSHAH S M, DEAOUKI M M, KOTERBA K L, et al. Expression of estrogen receptor coregulators in normal and malignant human endometrinm[J]. Gynecol Oncol, 2004,92 (1) 304-313.
  • 10王翠秀,王言奎,杨玲,徐冰,姜玉珍,郎胜利.核受体共激活因子AIB1在子宫内膜癌组织中的表达及其意义[J].青岛大学医学院学报,2007,43(5):383-386. 被引量:3

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部